Lopressor and Vertebral foraminal stenosis - a phase IV clinical study of FDA data

Summary:

Vertebral foraminal stenosis is reported as a side effect among people who take Lopressor (metoprolol tartrate), especially for people who are female, 40-49 old, also take Aredia, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Vertebral foraminal stenosis when taking Lopressor. It is created by eHealthMe based on reports of 32,072 people who have side effects when taking Lopressor from the FDA, and is updated regularly.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.

What is Vertebral foraminal stenosis?

Vertebral foraminal stenosis (narrowing of the intervertebral foramen) is found to be associated with 456 drugs and 351 conditions by eHealthMe. Check the latest studies of Vertebral foraminal stenosis.

On Jul, 30, 2026

32,072 people reported to have side effects when taking Lopressor.
Among them, 36 people (0.11%) have Vertebral foraminal stenosis.

Could Lopressor cause Vertebral foraminal stenosis?

Among these 36 people:

What is the gender of people who have Vertebral foraminal stenosis when taking Lopressor? *

female: 51.43 %
male: 48.57 %

What is the age of people who have Vertebral foraminal stenosis when taking Lopressor? *

What are other drugs people take besides Lopressor? *

What are other side effects people have besides Vertebral foraminal stenosis? *

Dyspnea (difficult or laboured breathing): 35 people, 97.22%
Osteonecrosis Of Jaw (death of bone of jaw): 34 people, 94.44%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 33 people, 91.67%
Intervertebral Disc Degeneration (spinal disc degeneration): 33 people, 91.67%
Bone Disorder: 33 people, 91.67%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 31 people, 86.11%
Spinal Osteoarthritis (joint cartilage loss in spine): 31 people, 86.11%
Back Pain: 31 people, 86.11%
Weakness: 30 people, 83.33%
Osteopenia (a condition where bone mineral density is lower than normal): 30 people, 83.33%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 20 people, 55.56%
Bone Loss: 12 people, 33.33%
Upper Respiratory Tract Infection: 2 people, 5.56%
Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 5.56%
Pain: 2 people, 5.56%
Muscle Spasms (muscle contraction): 2 people, 5.56%
Breast Cancer Metastatic: 2 people, 5.56%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 2 people, 5.56%
Stress And Anxiety: 1 person, 2.78%
Metastases To Bone (cancer spreads to bone): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Lopressor and have Vertebral foraminal stenosis?

- Check whether Vertebral foraminal stenosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lopressor:

Lopressor (33,152 reports)

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vertebral foraminal stenosis:

Vertebral foraminal stenosis (456 drugs)

Browse all the conditions that are associated with Vertebral foraminal stenosis:

Vertebral foraminal stenosis (351 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Lopressor) and Lopressor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.